李倩, 胡昱, 陈恩富, 陈雅萍, 严睿, 戚小华. 浙江省含麻疹成分疫苗常规免疫首剂接种率估算与评价[J]. 疾病监测, 2011, 26(7): 512-515. DOI: 10.3784/j.issn.1003-9961.2011.07.004
引用本文: 李倩, 胡昱, 陈恩富, 陈雅萍, 严睿, 戚小华. 浙江省含麻疹成分疫苗常规免疫首剂接种率估算与评价[J]. 疾病监测, 2011, 26(7): 512-515. DOI: 10.3784/j.issn.1003-9961.2011.07.004
LI Qian, HU Yu, CHEN En-fu, CHEN Ya-ping, YAN Rui, QI Xiao-hua. Evaluation on estimation of routine immunization coverage of the first dose of measles containing vaccine in Zhejiang province[J]. Disease Surveillance, 2011, 26(7): 512-515. DOI: 10.3784/j.issn.1003-9961.2011.07.004
Citation: LI Qian, HU Yu, CHEN En-fu, CHEN Ya-ping, YAN Rui, QI Xiao-hua. Evaluation on estimation of routine immunization coverage of the first dose of measles containing vaccine in Zhejiang province[J]. Disease Surveillance, 2011, 26(7): 512-515. DOI: 10.3784/j.issn.1003-9961.2011.07.004

浙江省含麻疹成分疫苗常规免疫首剂接种率估算与评价

Evaluation on estimation of routine immunization coverage of the first dose of measles containing vaccine in Zhejiang province

  • 摘要: 目的 估算浙江省含麻疹成分疫苗(measles containing vaccine,MCV)常规免疫首剂(MCV1)接种率。 方法 通过中国免疫规划监测信息管理系统收集MCV常规免疫报告接种率数据。通过麻疹监测信息报告管理系统,收集麻疹病例免疫史信息,以MCV的疫苗效力(vaccine efficacy, VE)对MCV1接种率进行估算。 结果 2008 - 2010年浙江省年均MCV1报告接种率99%。以麻疹病例中免疫史比例和VE估计的13~83月龄儿童MCV1接种率为76.65%(VE=82.9%)或90.53%(VE=95%);本地儿童MCV1接种率为85.86%(VE=82.9%)或95.40%(VE=95%),流动儿童MCV1接种率为67.54%(VE=82.9%)或87.68%(VE=95%)。MCV1及时(9月龄接种)接种率为61.16%(VE=82.9%)或84.34%(VE=95%)。 结论 估算接种率与报告接种率存在较大差距,MCV1接种率和及时接种率较低。为掌握真实的MCV接种率,应使用基于预防接种个案信息的常规免疫监测系统并采用多角度、多方法的接种率评估。

     

    Abstract: Objective To estimate the routine immunization coverage of the first dose of measles containing vaccine (MCV1) in Zhejiang. Methods The reported routine coverage data of MCV were collected from China immunization information system. The immunization history of measles cases were collected from China measles surveillance system and the estimated coverage was calculated based on vaccine efficacy (VE) of MCV. Results The reported coverage rate of MCV1 was >99% in Zhejiang province from 2008 to 2010. Based on the proportion of immunized measles cases and VE of MCV, the estimated coverage rate of MCV1 was 76.65% (VE=82.9%) or 90.53% (VE=95%) in children aged 13-83 months. The estimated coverage rate of MCV1 was 85.86% (VE=82.9%) or 95.40% (VE=95%) in local children and 67.54% (VE=82.9%) or 87.68% (VE=95%) in children among floating population. The timely immunization rate of MCV1 (9 months) was 61.16% (VE=82.9%) or 84.34% (VE=95%). Conclusion There is still a large gap between the reported coverage and the estimated coverage of MCV, and the coverage rate and timely coverage rate of MCV1 were still low. It is necessary to use routine immunization surveillance system based on children's immunization record to understand the real coverage rate of MCV in different estimation ways.

     

/

返回文章
返回